Oric Pharmaceuticals
0 followers
ORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on making cancer treatments more effective by addressing mechanisms of resistance. ORIC's lead asset, ORIC-101, is a potent and selective small-molecule antagonist of the glucocorticoid receptor. ORIC's pipeline target... Read more
Org chart
Jacob Chacko
CEO
Jacob Chacko
Collapse
Matt Panuwat
Chief Business Officer
Lori Friedman
Chief Scientific Officer
Pratik Multani
Chief Medical Officer
Christian V. Kuhlen
General Counsel
Edna Chow Maneval
Senior Vice President, Clinical Development
Dan Iazzetti
VP, Head of People
Sandy Koppenol
Director Of Formulation And Drug Delivery
Kevin Sun
Director Of IT Enterprise Applications
Chester Chae
Manager, Regulatory Affairs
Suzuko Kitazawa
Senior Manager
Teams
View all
